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Hemodialysis bone disease: Correlation between clinical, histo-
logical and other findings. This paper explores in patients with
dialysis osteodystrophy the relationship between clinical features
and histological, radiological, and biochemical findings. Eighty-
five patients treated by hemodialysis for more than 6 months were
studied. The following conclusions were drawn: 1) Bone pain in
patients on regular hemodialysis is usually a symptom of develop-
ing osteomalacia but not of hyperparathyroidism or osteoporosis.
2) Many patients with histological osteomalacia and radiological
features of osteomalacia, such as fractures or Looser zones, have
no symptoms. 3) In dialysis patients, biochemical and radiological
abnormalities are not a reliable means of predicting the presence of
osteomalacia, but a raised serum alkaline phosphatase is a good
indicator of the presence of osteitis fibrosa. For early detection
of osteomalacia, bone biopsy is necessary. 4) A number of our di-
alysis patients develop an unusual form of osteomalacia charac-
tenzed by absent or minimal histological osteitis fibrosa, a normal
serum alkaline phosphatase, and a high incidence of myopathy and
fractures.
Ostéopathie de l'hémodialyse: Correlation entre les constata-
tions cliniques, histologiques et autres. Ce travail étudie, chez des
malades atteints d'ostéopathie de l'hemodialyse, les relations entre
les aspects diniques et les constatations histologiques, radiolo-
giques et biochimiques. Quatre vingt cinq malades traités par
hemodialyse pendant plus de six mois ont été étudiés. Les conclu-
sions suivantes ont ét portees: I) Les douleurs osseuses chez des
malades en hemodialyse iterative sont habituellement un symp-
tome d'ostéomalacie en evolution mais non d'hyperparathy-
roidisme ou d'osteoporose. 2) De nombreux malades atteints
d'ostéomalacie histologique et ayant des signes mdi-
ologiques d'ostéomalacie telles des fractures ou des zones de
Looser, n'ont pas de symptomes. 3) Chez les malades en hémodia-
lyse les anomalies biochimiques et radiologiques ne sont pas des
moyens fiables d'évaluer la presence d'une ostéomalacie mais
l'augmentation de Ia phosphatase alcaline est un bon indicateur de
La presence d'une ostéite fibreuse. Pour Ia detection precoce de
l'ostéomalacie la biopsie osseuse est nécessaire. 4) Certains parmi
nos malades développent une forme inhabituelle d'ostéomalacie
caractérisee par l'absence ou le caractdre minime de l'ostéite
fibreuse, une phosphatase alcaline augmented et une fraquence
élevée de myopathies et de fractures.
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Although most patients on regular hemodialysis
show histologic abnormalities on iliac bone biopsies
[1—31, relatively few have symptoms of bone disease
[4—5]. The pattern of bone disease varies consider-
ably between dialysis centers [6—91, with a high
incidence of symptomatic disease in Newcastle upon
Tyne. Relatively few studies have explored the cor-
relations between clinical, biochemic, histologic, and
radiologic findings 15, 10—16], and they have pro-
duced conflicting conclusions. We have recently de-
scribed the correlation between radiology and histol-
ogy in 70 of our regular hemodialysis patients [171,
and we now present an analysis of the relationship
between clinical features and the biochemic, radio-
logic, and histologic findings in an overlapping group
of 85 patients.
Methods
The 85 patients studied had been on regular hemo-
dialysis for 6 to 96 months. Although most bone
biopsies were performed as part of a survey of the
incidence of histological abnormalities in the bone of
patients on regular hemodialysis, some were per-
formed to investigate troublesome symptoms, and
there is some bias in the selection, with a particularly
high number of patients with myopathy and bone
pain. The age range was from 18 to 61 yr, and there
were 51 males and 34 females. The patients were on
a 60-g protein diet with supplements of vitamins B
and C. They received dialysis therapy of six to eight
hour's duration three times per week, mainly with
Kiil type dialyzers and with a dialy sate calcium of 1.6
mmoles/liter. Seven patients had been taking either
dihydrotachysterol or vitamin D2 for at least six
months before they were studied, and 35 had been on
aluminium hydroxide, 6 with calcium carbonate sup-
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Table 1. Histologic assessments (iliac bone)
Total bone (normal, 16.6 to 28.8%)a
Total mineralized bone (normal, 16.5 to 28.6%)a
Total osteoid (normal, < 0.45%)a
Percentage mineralization (normal, > 98.2%)
Osteomalacia, based on:
An excess of osteoid
Increased number of birefringent lamellae in osteoid seams
(normal, up to 4)
Decreased calcification front in osteoid
Osteitis fibrosa, graded 0—5, based on
Surface resorption and tunnelling by multinucleated osteoclasts
Marrow fibrosis with increased osteoblast activity
Woven bone formation
a Percent of areas of microscopic fields occupied by the defined
structure.
plements, for a similar period. We excluded from the
study any patients in whom there had been a change
in such therapy during the six months before the
study, in case the time courses of any clinical, radio-
logic, biochemic, or histologic changes induced by
such changes in therapy were not parallel.
Clinical information was obtained using a standard
questionnaire, followed by discussion with the doc-
tor and clinical examination. Complaints of muscle
weakness were classified as subjective weakness. if
on clinical examination the patient was unable to rise
from the squatting position unaided three times in
succession, this was classified as objective weak-
ness. Bone pain was regarded as being due to osteo-
dystrophy if no other cause was apparent.
Biochemical parameters. The mean results of pre-
dialysis estimations of serum calcium, phosphate,
and alkaline phosphatase for the preceding three
months before bone biopsy were used for analysis.
Quantitative histologic analysis of iliac crest bone
biopsies was performed using the features listed in
Table 1 [1, 18]. Radiologic features used in the study
are listed in Table 2 [19, 20].
Table 2. Radiologic abnormalities
Subpeniosteal erosions in the phalanges
Abnormal mottling in the skull vault
Fractures and/or Looser zones
Sclerosis anywhere in the skeleton
Juxtaarticular rarefaction in the hands
Medullary rarefaction in the hands
a This is a radiologic appearance, which correlates with an
increased amount of osteoid. The anatomical basis of this appear-
ance is uncertain.
Results
Bone pain attributable to dialysis osteodystrophy
was present in 37 (44%) patients. Subjective weak-
ness was present in 39 (46%) patients, but only 24
(28%) had objective weakness. In seven patients, the
combination of pain and weakness led to severe
limitation of physical acitivity with inability to walk
unaided. Histologic osteomalacia was found in 60
(71%) patients, and osteitis fibrosa in 68 (80%). Ra-
diological fractures or Looser zones were present in
31(37%) patients, and subperiosteal erosions in 29
(34%).
When the clinical symptoms were compared with
the histologic findings (Table 3), it was found that
bone pain is associated with the histologic features of
osteomalacia but not with that of osteitis fibrosa.
There is no association between bone pain and histo-
logic osteoporosis or osteosclerosis. Radiologic fea-
tures of osteitis fibrosa, such as subperiosteal ero-
sions and skull mottling, showed no association with
bone pain (Table 4). As expected, there is a signifi-
cant association between bone pain and radiologic
fractures or Looser zones, but it is interesting that
30% of patients with fractures were asymptomatic
and that 45% of those with bone pain had no frac-
tures, showing that fractures are not the sole source
of bone pain. Patients with severe degrees ofjuxtaar-
ticular or medullary rarefaction in the metacarpals
suffered pain more frequently than the others.
Table 3. Association of symptoms with histologic changes in bone
Osteitis fibrosa
Total bonee Mineralized bone
—
Osteoide % Mineralizatione Osteomalacia grade
Low High pd Low High p <1 l P 95% <95% P - + P <2.5 >2.5 P
(14) (22) (17) (13) (22) (62) (26) (58) (25) (60) (66) (19)% % % % % % % % % % % %
Bone pain (37) 57 45 NS 59 38 NS 27 50 >0.05 23 53 <0.01 20 53 <0.01 45 37 NS
Objective muscle
weakness (24) 50 14 >0.05 47 23 >0.05 41 24 NS 27 29 NS 16 33 >0.05 30 21 NS
a Percentage figures represent the proportion of people with each histologic or radiologic feature who have the specified symptom, i.e.,
57% of people with a low total bone have bone pain, 21% of patients with osteitis fibrosa grade > 2.5 have objective muscle weakness.
b NS denotes P > 0.1. Numbers in parentheses indicate the total number of patients with that finding.
See Table 1 for normal range.
In these columns, x2 and hence P was obtained by comparing the high or low value with all other patients.
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Table 4. Association of symptoms with radiologic changes in bonea
Spinal Fractures or
Erosions Skull changes5 sclerosisc Looser zones Juxtaarticular scorer' Medullary scored
— + P — + P — + P — + P 0-1-2 3-4 P 0-1 2-3-4 P
(56) (29)% % (53) (15)% % (34) (33)% % (54) (31)% % (63)% (22)% (46)% (39)%
Bone pain (37) 48 38 NS 40 47 NS 47 39 NS 30 68 <0.001 32 77 <0.001 30 59 <0.01
Objective muscle
weakness (24) 35 14 >0.05 30 20 NS 35 24 NS 20 42 <0.05 19 55 <0.01 22 36 NS
a See footnotes a and b of Table 3. One patient had no quantitative assessment of his bone biopsy.
b No skull X-ray was available from 17 patients.
No spine X-ray was available from 18 patients.
d Refers to hand rarefaction scores (graded from 0 [nil] to 4 [severe]).
Objective muscle weakness tends to be more com-
mon in patients with histologic osteomalacia and is
significantly associated with the presence of frac-
tures and Looser zones (Tables 3 and 4). Myopathy
also tends to be associated with low total bone and
low mineralized bone histologically and with severe
degrees of juxtaarticular rarefaction radiologically.
There is no association between myopathy and the
histologic or radiologic features of osteitis fibrosa.
An elevated serum alkaline phosphatase (above 90
lU/liter) was found in 47 (55%) patients; it is associ-
ated with histologic osteitis fibrosa but not with os-
teomalacia (Fig. 1). An elevated serum alkaline phos-
phatase is associated with the presence of radiologic
erosions, skull mottling, and sclerosis of the spine,
but not with fractures, Looser zones, or rarefaction
scores (Table 5). The serum alkaline phosphatase
correlates well with total osteoid (Fig. 2) and also
with total bone (r = 0.97, P < 0.0001).
Predialysis serum calcium was below 2.05
mmoles/liter in 20% of patients and above 2.55
mmoles/liter in 10%. There is no association between
serum calcium levels and any clinical, histologic, or
radiologic finding. Predialysis serum phosphate was
elevated (above 1.6 mmoles/liter) in 74% of patients,
below 1.2 mmoles/liter in four patients, and subnor-
mal (below 0.8 mmoles/liter) in no patients. Serum
phosphate levels do not relate to any clinical, radio-
logic, or histologic finding.
Discussion
Dialysis osteodystrophy has many components,
including osteomalacia, osteitis fibrosa, osteopor-
osis, and osteosclerosis. There are probably many
factors influencing the appearance of each compo-
nent. There is not simply a progression of the osteo-
dystrophy of chronic renal failure [211. Our patients
with chronic renal failure who have not yet been
dialyzed have predominant osteitis fibrosa, with Os-
teomalacia sometimes occurring in addition but
rarely, if ever, alone: in our dialysis population,
osteomalacia increases in frequency and often devel-
ops independently of osteitis fibrosa. The incidence
of symptomatic dialysis osteodystrophy varies enor-
mously between dialysis centers [6, 7, 221. We and
others [41 have felt that this may reflect the differing
histologic changes seen in each center, centers with a
high incidence of hyperparathyroidism having a low
incidence of symptoms [9, 12] and centers with a
high incidence of symptoms having a high incidence
of osteomalacia [19, 23]. The data presented here
supports this idea for, as in nonrenal bone disease,
bone pain is almost exclusively related to osteomala-
cia and not osteitis fibrosa or osteoporosis.
Table 5. Association of radiologic bone changes and raised serum alkaline phosphatasea
Fractures or Juxtaarticular
Erosions Skull changesb Spinal sclerosis Looser zones scored Medullary scored
— + P — + P — + P — + P 0-1-2 3-4 P 0-1 2-3-4 P
(23) (24) (25) (13) (13) (24) (29) (18) (36) (11) (26) (21)% % % % % % 9/ % % % % %
Serum alk.
phosphatase,
90 lU/liter 42 80 <0.001 47 87 =0.005 38 72 <0.005 54 58 NS 57 50 NS 57 54 NS
a See footnotes a and b of Table 3,
No skull X-ray was available from 17 patients.
No spine X-ray was available from 18 patients.
Refers to hand rarefaction scores (graded 0 [nil] to 4 [severe]).
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0-4 5-6 >6
Degree of osteitis fibrosa Maximum no. of osteoid lamellae
Fig. 1. Serum alkaline phosphatase in patients with slight or
absent (grade 0 to 1) and more severe (grade 1.5 to 5) osteitis
fibrosa and in absent, mild, and more severe osteomalacia as
judged by the number of osteoid lamellae. The dotted lines repre-
sent the upper limit of normal serum alkaline phosphatase
concentration.
Bone pain is not entirely confined to patients with
osteomalacia: five of 25 patients without it have pain.
Of these five, one developed osteomalacia and frac-
tures within six months, one had mild osteitis fibrosa
and died shortly after being studied, one had severe
hyperparathyroidism with fractures, both fractures
and pain disappearing on therapy with dihydro-
tachysterol, and the remaining two patients had se-
vere osteitis fibrosa (grades 3 and 3.5), and also died
shortly after study. Thus, in three of these patients,
severe osteitis fibrosa seems to have been the cause
of bone pain. In centers with a high incidence of
florid osteitis fibrosa, this may contribute to disabil-
ity, especially with regard to fractures, tendon rup-
ture, and ectopic calcification [9, 24].
Although the onset of bone pain in a dialysis pa-
tient strongly suggests developing osteomalacia, this
cannot be relied upon to detect this lesion, as 47% of
patients with osteomalacia had no symptoms. Simi-
larly, radiologic changes, such as nonhealing rib frac-
tures and Looser zones in the pubic rami, were found
in many asymptomatic patients. Bone biopsy is the
only certain way of detecting the early development
of this potentially disabling condition.
The osteomalacia seen in our dialysis patients has
several unusual features not seen in most other forms
of osteomalacia or in predialysis renal osteodystro-
phy. Serum alkaline phosphatase levels are often
normal (Fig. 1), and bone biopsy specimens often
lack histologic evidence of osteitis fibrosa and show
inactive bones with very few active osteoblasts, a!-
though osteitis fibrosa was often present in previous
biopsies from these patients. A similar picture may
be seen with hypophosphatemia [25], but serum
phosphate levels were not low in our patients and
were not different in groups of patients with different
histological patterns of dialysis osteodystrophy.
It is the patients with normal alkaline phospha-
tase" osteomalacia who had the most disabling pain
and fractures, and it is in this group of patients that
myopathy is especially common, occurring in 13 of
29 such patients (45%) compared with 20% of the
remainder, (x2 = 5.98, P < 0.05). Our patients with
this form of osteomalacia have failed to respond to
therapy with l-a-hydroxylated vitamin D derivatives
[211. In our experience, like that of Ritz [26], myopa-
thy in these patients, unlike predialysis patients, also
fails to respond to therapy with vitamin D deri-
vatives.
The role of osteoporosis in producing symptoms is
difficult to define. The high standard error in histo-
logic examination of mineralized bones due to the
variation in bone biopsy site [1] renders assessment
of individual biopsies difficult, and histologic and
radiologic changes do not always parallel one an-
other. We have reported a high incidence of osteopo-
rosis in our dialysis population on the basis of a high
incidence ofjuxtaarticular and medullary rarefaction
on radiograph [191. Medullary rarefaction, however,
has been shown to correlate closely with osteomala-
cia [17], which may explain the association found
here between this and bone pain. Juxtaarticular rare-
faction in a recent survey did not correlate with any
histologic picture [17]. From our study, no signifi-
cant association between histologic osteoporosis and
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bone pain has been found. We must await the results
of studies with more sensitive techniques of assess-
ing bone mass, for example neutron activation analy-
sis and photon absorptiometry, before we make any
firm conclusions about the importance of osteo-
porosis.
Radiologic osteosclerosis of the spine is consid-
ered by some authors to be a feature of hyperpara-
thyroidism [4, 27] but it also occurs in osteomalacia
[281, and in our patients skeletal sclerosis correlated
with both osteomalacia and osteitis fibrosa [171.
There is no association between radiologic osteo-
sclerosis and symptoms in this series (Table 4).
Predictive value of biochemical changes. The ex-
pected correlation between serum alkaline phospha-
tase and osteitis fibrosa 119,15,29] was confirmed. A
rise of alkaline phosphatase was also associated with
radiologic features of hyperparathyroidism (Table 5).
The correlation between alkaline phosphatase and
osteid volume presumably reflects the fact that os-
teid volume is increased in hyperparathyroidism [11.
We could not find the relationship between serum
alkaline phosphatase and osteomalacia found by
some workers [5, 11, 16, 30] (Fig. 1). We think this
unusual finding is due to the fact that we have two
populations of patients with osteomalacia, one with
what might be described as the common pattern, and
the other with the "normal alkaline phosphatase"
form of osteomalacia. As this latter syndrome does
not respond to vitamin D derivatives, the serum
alkaline phosphatase is of some use in predicting
whether or not a dialysis patient with osteomalacia is
likely to respond to such treatment. No other bio-
chemical parameter measured had any diagnostic or
predictive value.
Reprint requests to Dr. D.N.S. Kerr, Department of Medicine,
Royal Victoria Infirmary, Newcastle upon Tyne, NE] 4LP,
England.
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